MRI-Guided Radiotherapy for Head and Neck Cancer
Trial Summary
What is the purpose of this trial?
The purpose of the study is to determine if it is feasible to use magnetic resonance imaging (MRI) to adjust a portion of radiation therapy for patients with head and neck squamous cell carcinoma . The technique under study will be used to personalize the study treatment based on response, keeping all treatments within standard of care guidelines.
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are on a stable dose of a medication like warfarin and have no issues with blood clotting, you may still participate.
What data supports the effectiveness of the treatment MRI-Guided Radiotherapy for Head and Neck Cancer?
Is MRI-guided radiotherapy safe for humans?
Intensity-modulated radiation therapy (IMRT), a form of MRI-guided radiotherapy, is generally considered safe and can reduce side effects by precisely targeting tumors while sparing nearby healthy tissues. However, there are some uncertainties about potential side effects, such as impacts on swallowing and the risk of secondary cancers, especially in younger patients.46789
How is MRI-Guided Radiotherapy with IMRT different from other treatments for head and neck cancer?
MRI-Guided Radiotherapy with Intensity-modulated radiotherapy (IMRT) is unique because it delivers precise radiation doses that conform closely to the shape of the tumor, minimizing damage to nearby healthy tissues. This precision helps reduce side effects like xerostomia (dry mouth) while maintaining effective tumor control, which is a significant advantage over conventional radiation techniques.26101112
Eligibility Criteria
This trial is for adults with squamous cell carcinoma of the head and neck who haven't had surgery, radiotherapy, or systemic therapy for their cancer. They must be able to have MRIs (no pacemakers or certain metals in body), not pregnant, willing to follow study rules, and have a good performance status indicating they can carry out daily activities.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Patients undergo adaptive radiotherapy boost for head/neck squamous cell carcinomas, with MR simulation for boost treatment planning.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Intensity-modulated radiotherapy (Procedure)
- Magnetic Resonance Guidance (Procedure)
Intensity-modulated radiotherapy is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Head and neck cancers
- Brain tumors
- Prostate cancer
- Head and neck cancers
- Brain tumors
- Prostate cancer
- Breast cancer
- Head and neck cancers
- Brain tumors
- Prostate cancer
- Head and neck cancers
- Brain tumors
- Prostate cancer
- Head and neck cancers
- Brain tumors
- Prostate cancer
- Head and neck cancers
- Brain tumors
- Prostate cancer